BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 23073327)

  • 21. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
    Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction.
    Ørbo A; Kaino T; Arnes M; Larsen K; Pettersen I; Moe B
    Acta Obstet Gynecol Scand; 2009; 88(11):1234-42. PubMed ID: 19900140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial hyperplasia - the dilemma of management remains: a retrospective observational study of 280 women.
    Daud S; Jalil SS; Griffin M; Ewies AA
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):172-5. PubMed ID: 21764501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incidence of endometrial carcinoma after hysterectomy for atypical hyperplasia or FIGO stage IA carcinoma diagnosed on endometrial biopsy or endometrial resection].
    Ploteau S; Squifflet JL; Berlière M; Marbaix E; Donnez J
    Bull Cancer; 2008 May; 95(5):556-62. PubMed ID: 18541521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women.
    Buccoliero AM; Gheri CF; Castiglione F; Garbini F; Barbetti A; Fambrini M; Bargelli G; Pappalardo S; Taddei A; Boddi V; Scarselli GF; Marchionni M; Taddei GL
    Cytopathology; 2007 Aug; 18(4):241-9. PubMed ID: 17559564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can concurrent high-risk endometrial carcinoma occur with atypical endometrial hyperplasia?
    Erdem B; Aşıcıoğlu O; Seyhan NA; Peker N; Ülker V; Akbayır Ö
    Int J Surg; 2018 May; 53():350-353. PubMed ID: 29665453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasia.
    Giede KC; Yen TW; Chibbar R; Pierson RA
    J Obstet Gynaecol Can; 2008 Oct; 30(10):896-901. PubMed ID: 19038073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
    Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
    Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
    Taylor J; McCluggage WG
    Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment.
    Gonthier C; Piel B; Touboul C; Walker F; Cortez A; Luton D; Daraï E; Koskas M
    Anticancer Res; 2015 Dec; 35(12):6799-804. PubMed ID: 26637899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
    Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
    Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic criteria for distinguishing endometrial adenocarcinoma from complex atypical endometrial hyperplasia.
    Mittal K; Salem A; Lo A
    Hum Pathol; 2014 Jan; 45(1):98-103. PubMed ID: 24182562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia.
    Matsuo K; Ramzan AA; Gualtieri MR; Mhawech-Fauceglia P; Machida H; Moeini A; Dancz CE; Ueda Y; Roman LD
    Gynecol Oncol; 2015 Nov; 139(2):261-7. PubMed ID: 26238457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
    Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
    Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent endometrial carcinoma in hysterectomy specimens in patients with histopathological diagnosis of endometrial hyperplasia in curettage specimens.
    Dolanbay M; Kutuk MS; Uludag S; Bulut AN; Ozgun MT; Ozcelik B; Serin IS
    Ginekol Pol; 2015 Oct; 86(10):753-8. PubMed ID: 26677585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical over- and under-estimation in patients who underwent hysterectomy for atypical endometrial hyperplasia diagnosed by endometrial biopsy: the predictive value of clinical parameters and diagnostic imaging.
    Kimura T; Kamiura S; Komoto T; Seino H; Tenma K; Ohta Y; Yamamoto T; Saji F
    Eur J Obstet Gynecol Reprod Biol; 2003 Jun; 108(2):213-6. PubMed ID: 12781414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance Characteristics of Endometrial Sampling in Diagnosis of Endometrial Carcinoma.
    Taraboanta C; Britton H; Plotkin A; Azordegan N; Clement PB; Gilks CB
    Int J Gynecol Pathol; 2020 Jan; 39(1):19-25. PubMed ID: 31815891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p53 in imprint smears of endometrial carcinoma.
    Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
    Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supervised clustering of immunohistochemical markers to distinguish atypical and non-atypical endometrial hyperplasia.
    Laas E; Ballester M; Cortez A; Gonin J; Canlorbe G; Daraï E; Graesslin O
    Gynecol Endocrinol; 2015 Apr; 31(4):282-5. PubMed ID: 25495249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.